J&J Questions $158M Settlement Of Texas' Risperdal Suit
A Johnson & Johnson unit will return to court Tuesday to voice concerns about a $158 million settlement with the state of Texas over allegations that it illegally marketed antipsychotic drug...To view the full article, register now.
Already a subscriber? Click here to view full article